CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 82.12% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money
36.78
5%
Market Trading Hours* (UTC) Opens on Monday at 14:30

Mon - Fri: 14:30 - 21:00

  • Summary
  • Historical Data
Trading сonditions
Spread 0.11
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.023512 %
Charges from full value of position ($-4.47)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.023512%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment 0.00129 %
Charges from full value of position ($0.25)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.00129%
Overnight fee time 22:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5.00%
Stock exchange United States of America
Commission on trade 0%

Key Stats
Prev. Close 35.03
Open 35.95
1-Year Change 74.94%
Day's Range 35.95 - 36.91
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Feb 21, 2025 36.78 0.98 2.74% 35.80 36.99 35.66
Feb 20, 2025 35.03 0.30 0.86% 34.73 35.12 34.42
Feb 19, 2025 35.02 1.01 2.97% 34.01 35.41 33.91
Feb 18, 2025 34.15 -0.75 -2.15% 34.90 35.30 33.94
Feb 14, 2025 34.94 0.71 2.07% 34.23 35.22 33.99
Feb 13, 2025 34.44 1.66 5.06% 32.78 34.55 32.65
Feb 12, 2025 32.64 -0.35 -1.06% 32.99 35.29 32.64
Feb 11, 2025 32.76 -0.20 -0.61% 32.96 33.07 32.25
Feb 10, 2025 33.44 0.04 0.12% 33.40 34.18 33.26
Feb 7, 2025 33.43 -0.11 -0.33% 33.54 33.61 33.01
Feb 6, 2025 33.59 0.20 0.60% 33.39 33.73 33.26
Feb 5, 2025 33.50 0.42 1.27% 33.08 33.55 33.08
Feb 4, 2025 33.07 0.11 0.33% 32.96 33.44 32.79
Feb 3, 2025 32.82 0.28 0.86% 32.54 33.23 32.32
Jan 31, 2025 33.08 0.43 1.32% 32.65 33.59 32.65
Jan 30, 2025 32.88 -0.12 -0.36% 33.00 33.23 32.60
Jan 29, 2025 32.88 0.29 0.89% 32.59 33.15 32.53
Jan 28, 2025 32.54 0.26 0.81% 32.28 33.00 32.24
Jan 27, 2025 32.56 -0.01 -0.03% 32.57 33.42 32.33
Jan 24, 2025 32.32 -0.55 -1.67% 32.87 33.42 31.81

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Exelixis Company profile

Exelixis, Inc., a biotechnology company, engages in the discovery, development, and commercialization of new medicines to enhance care and outcomes for people with cancer. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ capsules for the treatment of patients with progressive and metastatic medullary thyroid cancer. Its CABOMETYX and COMETRIQ are derived from cabozantinib, an inhibitor of multiple tyrosine kinases, including MET, AXL, RET, and VEGF receptors. It also offers COTELLIC tablets, an inhibitor of MEK in combination with vemurafenib for the treatment of patients with BRAF V600E or V600K mutation-positive advanced melanoma in the United States; and in combination with vemurafenib in other territories, including the European Union, Switzerland, Canada, Australia, and Brazil. Exelixis, Inc. has collaboration and license agreements with Ipsen Pharma SAS, Genentech, Inc., GlaxoSmithKline, Bristol-Myers Squibb Company, Sanofi, Merck, and Daiichi Sankyo Company Limited for the development and commercialization of various compounds and programs. The company was formerly known as Exelixis Pharmaceuticals, Inc. and changed its name to Exelixis, Inc. in February 2000. Exelixis, Inc. was founded in 1994 and is headquartered in South San Francisco, California.
Industry: Bio Therapeutic Drugs

1851 Harbor Bay Parkway
ALAMEDA
CALIFORNIA 94502
US

People also watch

ETH/USD

2,779.27 Price
+5.290% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 1.75

Gold

2,936.56 Price
-0.110% 1D Chg, %
Long position overnight fee -0.0149%
Short position overnight fee 0.0067%
Overnight fee time 22:00 (UTC)
Spread 0.30

US100

21,594.40 Price
-2.120% 1D Chg, %
Long position overnight fee -0.0235%
Short position overnight fee 0.0013%
Overnight fee time 22:00 (UTC)
Spread 7.0

BTC/USD

96,674.75 Price
+1.390% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 50.00

Still looking for a broker you can trust?

Join the 690,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading